Low Dose Naltrexone: A Promising Treatment for Crohn’s Disease

Are you suffering from Chrohn’s disease and looking for a solution to the chronic pain?

Crohn’s disease is a chronic inflammatory bowel disease that affects millions of people worldwide. It causes inflammation in the digestive tract, leading to symptoms like abdominal pain, diarrhoea, and weight loss. While there are various treatment options available for Crohn’s disease, including medications, surgery, and lifestyle changes, these options often come with unwanted side effects and are not always effective, and some sufferers must resort to using a life changing colostomy bag.

In recent years, Low Dose Naltrexone (LDN) has emerged as a promising treatment option for Crohn’s disease, with fewer side effects and potentially greater efficacy.

What is LDN?

Naltrexone is a drug that has been used for many years to treat addiction to opioids and alcohol. At high doses, it blocks the effects of these substances in the brain. However, at low doses, it has been shown to have incredibly effective anti-inflammatory effects.

How does LDN work?

LDN binds to certain receptors in the body that are involved in regulating the immune system, such as the Toll-like receptor 4 (TLR4) and the opioid growth factor receptor (OGFr). By binding to these receptors, LDN can reduce inflammation and improve symptoms in conditions like Crohn’s disease.

LDN’s mechanisms of action have been extensively studied in both animal models and human patients. LDN has been shown to regulate the activity of immune cells, such as T cells and B cells, and to increase the production of endogenous opioids, which are natural pain-relievers and have anti-inflammatory properties. LDN has also been shown to reduce the activity of pro-inflammatory proteins in the human body which are involved in the development of Crohn’s disease.

Evidence for LDN in Crohn’s Disease

Several studies have reported positive results for LDN in the treatment of Crohn’s disease. One small study found that 67% of patients experienced a clinical response to LDN, meaning their symptoms improved. Another larger study found that LDN was associated with a reduction in symptoms and an improvement in quality of life. LDN has been shown to be effective in both active and inactive Crohn’s disease, and to have a long-lasting effect.

LDN is generally well-tolerated, with few side effects. The most common side effects reported are mild, usually manifesting as headaches, nausea, and vivid dreams, which usually resolve within a few days of starting treatment. LDN does not interfere with other medications or treatments for Crohn’s disease, and can be safely used in combination with them.

Using LDN with Bodyline Wellness Clinics

If you suffer from Crohn’s disease, or any inflammatory diseases or chronic pain, LDN may be a great solution for you to significantly increase the quality of your life. In the form of a daily oral capsule, users have reported significant improvement in chronic pain in cases ranging from Crohn’s disease to Long Covid.

Here at Bodyline, we have over 15 years of clinical prescribing experience and expertise, and have helped tens of thousands of people medically improve their health problems. We are CQC certified, therefore we are regulated by the same institutional body that regulates NHS hospitals and general practices. Our medication has a safe and secure supply chain, and we work closely with UK laboratories to ensure the quality of our medications.

Crohn’s disease can be a challenging condition to manage, but LDN may offer a promising treatment option for those who have not responded well to other treatments. Its anti-inflammatory effects make it a potentially useful therapy for reducing symptoms and improving quality of life. With more research and clinical experience, LDN may become a standard treatment for Crohn’s disease in the future. Get ahead of the game and change your life now by getting in touch and calling us on 0800 995 6036 or filling in our online contact form for a call back.

About the author

Picture of Sally-Ann Turner

Sally-Ann Turner

I am the founder and Managing Director of Bodyline. I am passionate about providing tailored medical wellness treatments and industry leading clinical support that really make a positive difference to people’s lives. I am currently working across industry sectors to innovate women’s health solutions that deliver better patient outcomes in peri menopause and menopause.

Find me on LinkedIn

Related blog posts

Psoriasis is a chronic autoimmune condition that affects the skin, causing itchy and painful patches of red, scaly skin. It can be a debilitating condition, with many patients struggling to find effective treatments. However, low dose naltrexone (LDN) has shown promising results as a potential treatment for psoriasis.
Low Dose Naltrexone (LDN) is a medication that has been found to be effective in treating various medical conditions, including autoimmune diseases, chronic pain, and reported to have promising results for people with primary cancer. Despite its proven efficacy, LDN is not a licensed medicine in the UK, which makes it challenging to obtain. Fortunately, Bodyline offers a private prescription service for LDN that can help you access this medication.
Low Dose Naltrexone (LDN) is a medication that is gaining popularity in the medical community as a promising treatment option for a variety of conditions such as chronic pain, autoimmune diseases, and Crohn’s disease. Naltrexone has been used for decades to treat opioid addiction and alcoholism. It works by blocking the receptors in the brain that are responsible for the effects of these substances. When used in low doses, naltrexone has been found to have a completely different effect on the body.

CONTACT US TODAY

Contact Bodyline to find out more how we can treat and support you to improve your health and wellbeing.

"*" indicates required fields

Select the Bodyline treatment that you would like to discuss*
By submitting this form you agree to the Bodyline privacy policy.